ENTITY
SMARTSCORE: 3/5

Celldex Therapeutics (CLDX US)

3
Analysis
Health CareUnited States
Celldex Therapeutics Inc., a biopharmaceutical company, uses applications of immunology to prevent and treat diseases. The Company's products treat autoimmune diseases, cardiovascular diseases, cancer, and inflammation, as well as infectious diseases and organ transplant rejection.
more
01 Oct 2024 00:36Issuer-paid

Biopharma Week in Review - September 30, 2024

We review last week’s biopharma news for meaningful clinical data, regulatory updates, research innovation, and M&A. Last week, BMY received...

Logo
269 Views
Share
16 Aug 2022 13:39

Upgrading Discretionary to Overweight, Downgrading Energy & Health Care to Market Weight

Upgrading Discretionary $XLY to Overweight, Downgrading Energy $XLE & Health Care $XLV to Market Weight; Many indexes with major bullish...

Logo
330 Views
Share
bullishS&P 500 INDEX
15 Dec 2020 23:17

U.S. Equity Strategy: Bullish Outlook Intact; Growth Vs. Value Stalemate Continues

Market dynamics remain positive and there continues to be an absence of breakdowns across the broad indexes and Sectors. As a result we remain...

Logo
282 Views
Share
No more insights
x